Femasys Inc. (FEMY) NASDAQ

1.09

-0.06(-5.22%)

Updated at May 09 10:32AM

Currency In USD

Femasys Inc.

Address

3950 Johns Creek Court

Suwanee, GA 30024

United States of America

Phone

770 500 3910

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

69

First IPO Date

June 18, 2021

Key Executives

NameTitlePayYear Born
Ms. Kathy Lee-Sepsick M.B.A.Founder, President, Chief Executive Officer & Director661,2171968
Mr. Daniel Scott CurrieChief Operating Officer, Senior Vice President & Secretary491,3651964
Mr. Dov ElefantChief Financial Officer548,8041967
Ms. Naomi PhaneufVice President of Marketing0N/A
Mr. Richard SpectorChief Commercial Officer01971
Dr. Jeffrey Marcus M.D., M.S.Chief Medical Advisor0N/A
Ms. Mary An Merchant J.D., Ph.D.Vice President of Counsel & Intellectual Property0N/A
Ms. Christine ThomasSenior Vice President of Regulatory & Clinical Affairs01973
Mr. Benjamin DingsVice President of Sales0N/A
Dr. James H. Liu M.D.Chief Medical Officer0N/A

Description

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.